Open Access Open Access  Restricted Access Subscription Access

Understanding the Mechanisms of Drugs Acting on Opioid Analgesics

Muralinath E., Pooja Devi, Prasanta Chbukdhara, Sanjib Borah, Kalyan C., Archana Jain, Guruprasad M.

Abstract


Opioid analgesics are useful in decreasing pain. They perform their effects by binding to specific receptors in CNS and modulate pain perception. Opioid receptors categorized as delta , kappa and mu, are integral to the Opioid system. The distribution of these receptors happens throughout the brain and Spinal cord. Endogenous ligands namely endorphins and enkephalins naturally bind to these receptors to control pain perception. Morphine, a class of Opioid agonist, specifically vtargets mu receptors. It decreases pain by dampening the transmission of pain signals in the Spinal cord and modify the perception of pain in the brain. Other common Opioid agonists include oxycodone, hydromorhone and fentanyl each varying in potency and duration of action. Burenorphine, a partial receptor agonist is commonly used in Opioid addition treatment. Naloxone and naltrexone are potent opioid antagonists used in emergency conditions, such as Opioid overdose.pentazocine acts as a mixed agonist _ antagonist and provide analgesics via kappa receptors does not provide analgesia by blocking mu receptors. Cytochrome P 450 enzymes, especially CYP 3 A 4 play an important role in the metabolizing many opioids. Drug interactions influence these enzymes can alter Opioid concentrations and impact both therapeutic effects as well as side effects. Finally it is concluded that understanding intricate mechanisms of drugs acting on. Opioid analgesics is critical for optimizing the risks related to their use.


Full Text:

PDF

References


Jamison RN, Mao J. Opioid Analgesics. Mayo Clin Proc. 2015 Jul;90(7) 957-68. [PubMed]

Guy GP, Zhang K, Bohm MK, Losby J, Lewis B, Young R, Murphy LB, Dowell D. Vital Signs Changes in Opioid Prescribing in the United States, 2006-2015. MMWR Morb Mortal Wkly Rep. 2017 Jul 07;66(26) 697-704. [PMC free article] [PubMed]

Chakote K, Guggenheimer J. Implications of use of opioid-containing analgesics for palliation of acute dental pain. J Opioid Manag. 2019 Jan/Feb;15(1) 35-41. [PubMed]

Aubrun F, Nouette-Gaulain K, Fletcher D, Belbachir A, Beloeil H, Carles M, Cuvillon P, Dadure C, Lebuffe G, Marret E, Martinez V, Olivier M, Sabourdin N, Zetlaoui P. Revision of expert panel's guidelines on postoperative pain management. Anaesth Crit Care Pain Med. 2019 Aug;38(4) 405-411. [PubMed]

Zöllner C, Stein C. Opioids. Handb Exp Pharmacol. 2007;(177) 31-63. [PubMed]

Aiyer R, Mehta N, Gungor S, Gulati A. A Systematic Review of NMDA Receptor Antagonists for Treatment of Neuropathic Pain in Clinical Practice. Clin J Pain. 2018 May;34(5) 450-467. [PubMed]

Crockett SD, Greer KB, Heidelbaugh JJ, Falck-Ytter Y, Hanson BJ, Sultan S., American Gastroenterological Association Institute Clinical Guidelines Committee. American Gastroenterological Association Institute Guideline on the Medical Management of Opioid-Induced Constipation. Gastroenterology. 2019 Jan;156(1) 218-226. [PubMed]

Smischney NJ, Pollard EM, Nookala AU, Olatoye OO. Serotonin Syndrome in the Perioperative Setting. Am J Case Rep. 2018 Jul 16;19 833-835. [PMC free article] [PubMed]

Dowell D, Haegerich TM, Chou R. CDC Guideline for Prescribing Opioids for Chronic Pain--United States, 2016. JAMA. 2016 Apr 19;315(15) 1624-45. [PMC free article] [PubMed]

Kuczyńska K, Grzonkowski P, Kacprzak Ł, Zawilska JB. Abuse of fentanyl An emerging problem to face. Forensic Sci Int. 2018 Aug;289 207-214. [PubMed]


Refbacks

  • There are currently no refbacks.